相关实验视频

Updated: May 28, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

揭示CLL-1的潜力:在AML治疗中是一个有希望的目标

Hamed Soleimani Samarkhazan¹, Sara Zehtabcheh², Hamideh Rahmani Seraji³

¹Student Research Committee, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Biomarker research

|February 12, 2025

概括

甲样分子-1 (CLL-1) 是急性髓性白血病 (AML) 治疗的一个有前途的标. 它在癌细胞上的高表达有助于诊断,监测最小残留疾病 (MRD) 和开发免疫疗法,以获得更好的患者结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

急性髓性白血病 (AML) 在治疗,复发和耐药性方面存在重大挑战.
新的治疗目标对于改善AML患者的治疗结果至关重要.
类型C的甲酸样分子-1 (CLL-1) 是细胞表面受体,在AML爆发中高度表达.

研究的目的:

审查CLL-1在AML中的结构,功能和表达.
探索CLL-1作为诊断标记物和最小残留疾病 (MRD) 监测的潜力.
检查CLL-1在开发AML新型免疫疗法的作用.

主要方法:

关于CLL-1在AML中的表达和功能的文献综述.
对CLL-1在诊断和MRD检测中的实用性的分析.
对针对CLL-1的新兴免疫治疗策略的评估,包括CAR-T细胞疗法和抗体药物合物 (ADC).

主要成果:

在AML爆发中,CLL-1的表达一致,使其成为可靠的标记物.
稳定的CLL-1表达促进了MRD监测,这是复发的预测因素.
对于开发针对性免疫疗法来治疗AML,CLL-1是一个可行的标.

结论:

对于AML诊断,MRD监测和免疫治疗来说,CLL-1是一个重要的目标.
准CLL-1为新的治疗策略和改善患者治疗结果提供了潜力.
进一步了解CLL-1在AML发病过程中的作用将推动先进治疗方法的开发.

关键词:

这是一种C型学类分子-1-1 .移植对宿主疾病 (GVHD) 是一种移植对宿主疾病.免疫调节是一种免疫调节.免疫治疗是一种免疫疗法.炎症炎症是一种炎症.巨细胞是一个巨细胞.移植移植移植移植

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...